{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:56:01Z","timestamp":1788569761080,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["(grant number: TJYXZDXK-059B to YL, number: ZD04)"],"award-info":[{"award-number":["(grant number: TJYXZDXK-059B to YL, number: ZD04)"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["(grant number: TJYXZDXK-059B to YL, number: ZD04)"],"award-info":[{"award-number":["(grant number: TJYXZDXK-059B to YL, number: ZD04)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-024-02461-4","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T15:02:12Z","timestamp":1723734132000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Correlations of PSGL-1 VNTR polymorphism with the susceptibility to severe HFMD associated with EV-71 and the immune status after infection"],"prefix":"10.1186","volume":"21","author":[{"given":"Xia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqiang","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunyan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"key":"2461_CR1","doi-asserted-by":"publisher","unstructured":"Sarma N. Hand, foot, and mouth disease: current scenario and Indian perspective. Indian J Dermatol Venereol Leprol. 2013 Mar-Apr;79(2):165\u2009\u2013\u200975. https:\/\/doi.org\/10.4103\/0378-6323.107631. PMID: 23442455.","DOI":"10.4103\/0378-6323.107631"},{"issue":"4","key":"2461_CR2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.4103\/idoj.idoj_423_22","volume":"14","author":"S Tikute","year":"2023","unstructured":"Tikute S, Lavania M, Hand. Foot, and Mouth Disease (HFMD) in India: a review on clinical manifestations, Molecular Epidemiology, Pathogenesis, and Prevention. Indian Dermatol Online J. 2023;14(4):475\u201381. https:\/\/doi.org\/10.4103\/idoj.idoj_423_22. PMID: 37521225; PMCID: PMC10373810.","journal-title":"Indian Dermatol Online J"},{"issue":"3","key":"2461_CR3","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3390\/v16030352","volume":"16","author":"YP Lee","year":"2024","unstructured":"Lee YP, Yu CK, Wong TW, Chen LC, Huang BM. Cordycepin inhibits Enterovirus A71 Replication and protects host cell from Virus-Induced cytotoxicity through Adenosine Action Pathway. Viruses. 2024;16(3):352. https:\/\/doi.org\/10.3390\/v16030352. PMID: 38543718; PMCID: PMC10974990.","journal-title":"Viruses"},{"issue":"3","key":"2461_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10096-018-3206-x","volume":"37","author":"S Esposito","year":"2018","unstructured":"Esposito S, Principi N. Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention. Eur J Clin Microbiol Infect Dis. 2018;37(3):391\u20138. https:\/\/doi.org\/10.1007\/s10096-018-3206-x. Epub 2018 Feb 6. PMID: 29411190.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"2461_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/17460441.2021.1965987","volume":"17","author":"CY Fang","year":"2022","unstructured":"Fang CY, Liu CC. Novel strategies for the development of hand, foot, and mouth disease vaccines and antiviral therapies. Expert Opin Drug Discov. 2022;17(1):27\u201339. Epub 2021 Aug 19. PMID: 34382876.","journal-title":"Expert Opin Drug Discov"},{"issue":"2","key":"2461_CR6","doi-asserted-by":"publisher","first-page":"e0008885","DOI":"10.1371\/journal.pntd.0008885","volume":"15","author":"N Min","year":"2021","unstructured":"Min N, Ong YHB, Han AX, Ho SX, Yen EWP, Ban KHK, Maurer-Stroh S, Chong CY, Chu JJH. An epidemiological surveillance of hand foot and mouth disease in paediatric patients and in community: a Singapore retrospective cohort study, 2013\u20132018. PLoS Negl Trop Dis. 2021;15(2):e0008885. https:\/\/doi.org\/10.1371\/journal.pntd.0008885. PMID: 33566802; PMCID: PMC7901731.","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"2461_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3390\/v16040573","volume":"16","author":"A Yang","year":"2024","unstructured":"Yang A, Luo Y, Yang J, Xie T, Wang W, Wan X, Wang K, Pang D, Yang D, Dai H, Wu J, Meng S, Guo J, Wang Z, Shen S. Quantitation of Enterovirus A71 empty and full particles by Sedimentation Velocity Analytical Ultracentrifugation. Viruses. 2024;16(4):573. https:\/\/doi.org\/10.3390\/v16040573. PMID: 38675915; PMCID: PMC11053756.","journal-title":"Viruses"},{"issue":"5","key":"2461_CR8","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/bpa.12279","volume":"25","author":"KC Ong","year":"2015","unstructured":"Ong KC, Wong KT. Understanding Enterovirus 71 neuropathogenesis and its impact on other Neurotropic enteroviruses. Brain Pathol. 2015;25(5):614\u201324. https:\/\/doi.org\/10.1111\/bpa.12279. PMID: 26276025; PMCID: PMC8029433.","journal-title":"Brain Pathol"},{"issue":"11","key":"2461_CR9","doi-asserted-by":"publisher","first-page":"e0206769","DOI":"10.1371\/journal.pone.0206769","volume":"13","author":"TY Yen","year":"2018","unstructured":"Yen TY, Shih WL, Huang YC, Lee JT, Huang LM, Chang LY. Polymorphisms in enterovirus 71 receptors associated with susceptibility and clinical severity. PLoS ONE. 2018;13(11):e0206769. https:\/\/doi.org\/10.1371\/journal.pone.0206769. PMID: 30395634; PMCID: PMC6218064.","journal-title":"PLoS ONE"},{"issue":"11","key":"2461_CR10","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.3390\/v7112920","volume":"7","author":"HI Huang","year":"2015","unstructured":"Huang HI, Shih SR. Neurotropic enterovirus infections in the Central Nervous System. Viruses. 2015;7(11):6051\u201366. https:\/\/doi.org\/10.3390\/v7112920. PMID: 26610549; PMCID: PMC4664993.","journal-title":"Viruses"},{"key":"2461_CR11","doi-asserted-by":"publisher","first-page":"648184","DOI":"10.3389\/fimmu.2021.648184","volume":"12","author":"MY Lu","year":"2021","unstructured":"Lu MY, Lin YL, Kuo Y, Chuang CF, Wang JR, Liao F. Muscle tissue damage and Recovery after EV71 infection correspond to dynamic macrophage phenotypes. Front Immunol. 2021;12:648184. https:\/\/doi.org\/10.3389\/fimmu.2021.648184. PMID: 34305887; PMCID: PMC8299204.","journal-title":"Front Immunol"},{"issue":"7","key":"2461_CR12","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/nm.1961","volume":"15","author":"Y Nishimura","year":"2009","unstructured":"Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med. 2009;15(7):794\u20137. https:\/\/doi.org\/10.1038\/nm.1961. Epub 2009 Jun 21. PMID: 19543284.","journal-title":"Nat Med"},{"issue":"10","key":"2461_CR13","doi-asserted-by":"publisher","first-page":"5686","DOI":"10.1128\/JVI.00020-12","volume":"86","author":"S Yamayoshi","year":"2012","unstructured":"Yamayoshi S, Iizuka S, Yamashita T, Minagawa H, Mizuta K, Okamoto M, Nishimura H, Sanjoh K, Katsushima N, Itagaki T, Nagai Y, Fujii K, Koike S. Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71. J Virol. 2012;86(10):5686\u201396. https:\/\/doi.org\/10.1128\/JVI.00020-12. Epub 2012 Mar 21. PMID: 22438546; PMCID: PMC3347270.","journal-title":"J Virol"},{"key":"2461_CR14","doi-asserted-by":"publisher","unstructured":"Li XW, Ni X, Qian SY, Wang Q, Jiang RM, Xu WB, Zhang YC, Yu GJ, Chen Q, Shang YX, Zhao CS, Yu H, Zhang T, Liu G, Deng HL, Gao J, Ran XG, Yang QZ, Xu BL, Huang XY, Wu XD, Bao YX, Chen YP, Chen ZH, Liu QQ, Lu GP, Liu CF, Wang RB, Zhang GL, Gu F, Xu HM, Li Y, Yang T. Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition). World J Pediatr. 2018;14(5):437\u2013447. https:\/\/doi.org\/10.1007\/s12519-018-0189-8. Epub 2018 Oct 3. PMID: 30280313.","DOI":"10.1007\/s12519-018-0189-8"},{"issue":"1","key":"2461_CR15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12985-021-01605-0","volume":"18","author":"X Wang","year":"2021","unstructured":"Wang X, Liu H, Li Y, Su R, Liu Y, Qiao K. Relationship between polymorphism of receptor SCARB2 gene and clinical severity of enterovirus-71 associated hand-foot-mouth disease. Virol J. 2021;18(1):132. https:\/\/doi.org\/10.1186\/s12985-021-01605-0. PMID: 34193186; PMCID: PMC8244142.","journal-title":"Virol J"},{"key":"2461_CR16","doi-asserted-by":"publisher","unstructured":"Li R, Liu L, Mo Z, Wang X, Xia J, Liang Z, Zhang Y, Li Y, Mao Q, Wang J, Jiang L, Dong C, Che Y, Huang T, Jiang Z, Xie Z, Wang L, Liao Y, Liang Y, Nong Y, Liu J, Zhao H, Na R, Guo L, Pu J, Yang E, Sun L, Cui P, Shi H, Wang J, Li Q. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med. 2014;370(9):829\u2009\u2013\u200937. https:\/\/doi.org\/10.1056\/NEJMoa1303224. PMID: 24571755.","DOI":"10.1056\/NEJMoa1303224"},{"key":"2461_CR17","doi-asserted-by":"publisher","unstructured":"Zhu F, Xu W, Xia J, Liang Z, Liu Y, Zhang X, Tan X, Wang L, Mao Q, Wu J, Hu Y, Ji T, Song L, Liang Q, Zhang B, Gao Q, Li J, Wang S, Hu Y, Gu S, Zhang J, Yao G, Gu J, Wang X, Zhou Y, Chen C, Zhang M, Cao M, Wang J, Wang H, Wang N. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med. 2014;370(9):818\u2009\u2013\u200928. https:\/\/doi.org\/10.1056\/NEJMoa1304923. PMID: 24571754.","DOI":"10.1056\/NEJMoa1304923"},{"issue":"52","key":"2461_CR18","doi-asserted-by":"publisher","first-page":"9668","DOI":"10.1016\/j.vaccine.2011.10.018","volume":"29","author":"Z Liang","year":"2011","unstructured":"Liang Z, Mao Q, Gao Q, Li X, Dong C, Yu X, Yao X, Li F, Yin W, Li Q, Shen X, Wang J. Establishing China\u2019s national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines. Vaccine. 2011;29(52):9668\u201374. https:\/\/doi.org\/10.1016\/j.vaccine.2011.10.018. Epub 2011 Oct 19. PMID: 22015395.","journal-title":"Vaccine"},{"key":"2461_CR19","doi-asserted-by":"publisher","first-page":"199108","DOI":"10.1016\/j.virusres.2023.199108","volume":"330","author":"H Xie","year":"2023","unstructured":"Xie H, Yang E, Wang C, Peng C, Ji L. Targeting HDAC11 activity by FT895 restricts EV71 replication. Virus Res. 2023;330:199108. https:\/\/doi.org\/10.1016\/j.virusres.2023.199108. Epub 2023 Apr 15. PMID: 37024058; PMCID: PMC10194106.","journal-title":"Virus Res"},{"issue":"1","key":"2461_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12929-023-00908-4","volume":"30","author":"P Zhu","year":"2023","unstructured":"Zhu P, Ji W, Li D, Li Z, Chen Y, Dai B, Han S, Chen S, Jin Y, Duan G. Current status of hand-foot-and-mouth disease. J Biomed Sci. 2023;30(1):15. https:\/\/doi.org\/10.1186\/s12929-023-00908-4. PMID: 36829162; PMCID: PMC9951172.","journal-title":"J Biomed Sci"},{"issue":"12","key":"2461_CR21","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1111\/1756-185X.13151","volume":"21","author":"F Cosan","year":"2018","unstructured":"Cosan F, Oku B, Gedar Totuk OM, Abaci N, Ustek D, Diz Kucukkaya R, Gul A. The association between P selectin glycoprotein ligand 1 gene variable number of tandem repeats polymorphism and risk of thrombosis in Beh\u00e7et\u2019s disease. Int J Rheum Dis. 2018;21(12):2175\u20139. Epub 2017 Aug 14. PMID: 28809090.","journal-title":"Int J Rheum Dis"},{"key":"2461_CR22","doi-asserted-by":"publisher","unstructured":"Carlow DA, Gossens K, Naus S, Veerman KM, Seo W, Ziltener HJ. PSGL-1 function in immunity and steady state homeostasis. Immunol Rev. 2009;230(1):75\u201396. https:\/\/doi.org\/10.1111\/j.1600-065X.2009.00797.x. PMID: 19594630.","DOI":"10.1111\/j.1600-065X.2009.00797.x"},{"issue":"7","key":"2461_CR23","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1038\/emi.2014.49","volume":"3","author":"S Yamayoshi","year":"2014","unstructured":"Yamayoshi S, Fujii K, Koike S. Receptors for enterovirus 71. Emerg Microbes Infect. 2014;3(7):e53. https:\/\/doi.org\/10.1038\/emi.2014.49. Epub 2014 Jul 16. PMID: 26038749; PMCID: PMC4126179.","journal-title":"Emerg Microbes Infect"},{"issue":"8","key":"2461_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00109-003-0459-2","volume":"81","author":"P Bugert","year":"2003","unstructured":"Bugert P, Hoffmann MM, Winkelmann BR, Vosberg M, Jahn J, Entelmann M, Katus HA, M\u00e4rz W, Mansmann U, Boehm BO, Goerg S, Kl\u00fcter H. The variable number of tandem repeat polymorphism in the P-selectin glycoprotein ligand-1 gene is not associated with coronary heart disease. J Mol Med (Berl). 2003;81(8):495\u2013501. https:\/\/doi.org\/10.1007\/s00109-003-0459-2. Epub 2003 Jul 16. PMID: 12879153.","journal-title":"J Mol Med (Berl)"},{"key":"2461_CR25","doi-asserted-by":"publisher","unstructured":"Hancer VS, Diz-Kucukkaya R, Nalcaci M. Turkish population data on the factor XIII Val34Leu,glycoprotein (GP)Ibalpha Kozak and P-selectin glycoprotein ligand 1 (PSGL-1) loci. Cell Biochem Funct. 2005 Jan-Feb;23(1):55\u2009\u2013\u20098. https:\/\/doi.org\/10.1002\/cbf.1150. PMID: 15386532.","DOI":"10.1002\/cbf.1150"},{"key":"2461_CR26","doi-asserted-by":"publisher","unstructured":"Afshar-Kharghan V, Diz-K\u00fc\u00e7\u00fckkaya R, Ludwig EH, Marian AJ, L\u00f3pez JA. Human polymorphism of P-selectin glycoprotein ligand 1 attributable to variable numbers of tandem decameric repeats in the mucinlike region. Blood. 2001;97(10):3306-7. https:\/\/doi.org\/10.1182\/blood.v97.10.3306. PMID: 11342464.","DOI":"10.1182\/blood.v97.10.3306"},{"key":"2461_CR27","doi-asserted-by":"publisher","unstructured":"Lozano ML, Gonz\u00e1lez-Conejero R, Corral J, Rivera J, Iniesta JA, Martinez C, Vicente V. Polymorphisms of P-selectin glycoprotein ligand-1 are associated with neutrophil-platelet adhesion and with ischaemic cerebrovascular disease. Br J Haematol. 2001;115(4):969\u2009\u2013\u200976. https:\/\/doi.org\/10.1046\/j.1365-2141.2001.03151.x. PMID: 11843835.","DOI":"10.1046\/j.1365-2141.2001.03151.x"},{"key":"2461_CR28","doi-asserted-by":"publisher","unstructured":"Rold\u00e1n V, Gonz\u00e1lez-Conejero R, Mar\u00edn F, Pineda J, Vicente V, Corral J. Short alleles of P-selectin glycoprotein ligand-1 protect against premature myocardial infarction. Am Heart J. 2004;148(4):602-5. https:\/\/doi.org\/10.1016\/j.ahj.2004.04.020. PMID: 15459589.","DOI":"10.1016\/j.ahj.2004.04.020"},{"issue":"4","key":"2461_CR29","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.chom.2013.03.010","volume":"13","author":"OO Koyuncu","year":"2013","unstructured":"Koyuncu OO, Hogue IB, Enquist LW. Virus infections in the nervous system. Cell Host Microbe. 2013;13(4):379\u201393. https:\/\/doi.org\/10.1016\/j.chom.2013.03.010. PMID: 23601101; PMCID: PMC3647473.","journal-title":"Cell Host Microbe"},{"issue":"3","key":"2461_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1086\/345905","volume":"36","author":"TY Lin","year":"2003","unstructured":"Lin TY, Hsia SH, Huang YC, Wu CT, Chang LY. Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin Infect Dis. 2003;36(3):269\u201374. https:\/\/doi.org\/10.1086\/345905. Epub 2003 Jan 13. PMID: 12539066.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2461_CR31","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/labinvest.2011.82","volume":"91","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Cui W, Liu L, Wang J, Zhao H, Liao Y, Na R, Dong C, Wang L, Xie Z, Gao J, Cui P, Zhang X, Li Q. Pathogenesis study of enterovirus 71 infection in rhesus monkeys. Lab Invest. 2011;91(9):1337\u201350. https:\/\/doi.org\/10.1038\/labinvest.2011.82. Epub 2011 May 9. PMID: 21555996.","journal-title":"Lab Invest"},{"issue":"9","key":"2461_CR32","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.prp.2017.07.004","volume":"213","author":"YY Gu","year":"2017","unstructured":"Gu YY, Shi K, Yao S, Yang X, Liu YH, Tang L, Dang YW, Chen G, Feng ZB, Pan HB. Morphological characteristics of fatal pediatric hand, foot and mouth disease: a clinicopathological study with related receptors of EV71. Pathol Res Pract. 2017;213(9):1144\u201351. Epub 2017 Jul 6. PMID: 28756983.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"2461_CR33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1172\/JCI3001","volume":"102","author":"ZM Dong","year":"1998","unstructured":"Dong ZM, Chapman SM, Brown AA, Frenette PS, Hynes RO, Wagner DD. The combined role of P- and E-selectins in atherosclerosis. J Clin Invest. 1998;102(1):145\u201352. https:\/\/doi.org\/10.1172\/JCI3001. PMID: 9649568; PMCID: PMC509076.","journal-title":"J Clin Invest"},{"key":"2461_CR34","doi-asserted-by":"crossref","unstructured":"Norman KE, Moore KL, McEver RP, Ley K. Leukocyte rolling in vivo is mediated by P-selectin glycoprotein ligand-1. Blood. 1995;86(12):4417-21. PMID: 8541529.","DOI":"10.1182\/blood.V86.12.4417.bloodjournal86124417"},{"key":"2461_CR35","doi-asserted-by":"publisher","unstructured":"Klinkhardt U, Dragutinovic I, Harder S. P-selectin (CD62p) and P-selectin glycoprotein ligand-1 (PSGL-1) polymorphisms: minor phenotypic differences in the formation of platelet-leukocyte aggregates and response to clopidogrel. Int J Clin Pharmacol Ther. 2005;43(6):255\u2009\u2013\u200963. https:\/\/doi.org\/10.5414\/cpp43255. PMID: 15968882.","DOI":"10.5414\/cpp43255"},{"issue":"5","key":"2461_CR36","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.it.2017.02.002","volume":"38","author":"R Tinoco","year":"2017","unstructured":"Tinoco R, Otero DC, Takahashi AA, Bradley LM. PSGL-1: a New Player in the Immune Checkpoint Landscape. Trends Immunol. 2017;38(5):323\u201335. https:\/\/doi.org\/10.1016\/j.it.2017.02.002. Epub 2017 Mar 2. PMID: 28262471; PMCID: PMC5411281.","journal-title":"Trends Immunol"},{"key":"2461_CR37","doi-asserted-by":"publisher","unstructured":"Barbaux S, Poirier O, Pincet F, Hermand P, Tiret L, Deterre P. The adhesion mediated by the P-selectin P-selectin glycoprotein ligand-1 (PSGL-1) couple is stronger for shorter PSGL-1 variants. J Leukoc Biol. 2010;87(4):727\u2009\u2013\u200934. https:\/\/doi.org\/10.1189\/jlb.0609408. Epub 2010 Jan 5. PMID: 20051472.","DOI":"10.1189\/jlb.0609408"},{"key":"2461_CR38","doi-asserted-by":"publisher","unstructured":"Ozben B, Diz-Kucukkaya R, Bilge AK, Hancer VS, Oncul A. The association of P-selectin glycoprotein ligand-1 VNTR polymorphisms with coronary stent restenosis. J Thromb Thrombolysis. 2007;23(3):181-7. https:\/\/doi.org\/10.1007\/s11239-006-9020-9. PMID: 17221329.","DOI":"10.1007\/s11239-006-9020-9"},{"issue":"4","key":"2461_CR39","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1086\/376998","volume":"188","author":"SM Wang","year":"2003","unstructured":"Wang SM, Lei HY, Huang KJ, Wu JM, Wang JR, Yu CK, Su IJ, Liu CC. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis. 2003;188(4):564\u201370. https:\/\/doi.org\/10.1086\/376998. Epub 2003 Jul 23. PMID: 12898444.","journal-title":"J Infect Dis"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02461-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-024-02461-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02461-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T15:03:11Z","timestamp":1723734191000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-024-02461-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2461"],"URL":"https:\/\/doi.org\/10.1186\/s12985-024-02461-4","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]},"assertion":[{"value":"2 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the guidelines of the Declaration of Helsinki, and the protocol was approved by the Institutional Review Board of Medical Ethics Committee of Tianjin Second People\u2019s Hospital (Approval Certificate of Ethical Review No. 201825, No. 202142). Informed consent was obtained from all subjects and their parents\/legal guardian(s).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"187"}}